“Latent herpes viruses have the potential to reactivate in people living with HIV which can lead to neuroinflammation and impact long-term brain health,” said Shirin Mazumder, MD, infectious diseases ...

The Journey to a Vaccine,” a new documentary, premiered at Boston’s Museum of Science. The premiere was preceded by a ...

A single daily pill shows promise as replacement for complex, multi-tablet HIV treatment regimens according to the findings of a new phase 3 clinical trial, published in The Lancet. The study was ...

An upcoming multi-million dollar study at the University of Rochester aims to explore whether an HIV drug can slow aging and combat diseases like dementia and diabetes.Chief Investigative Reporter ...

Backed by $22 million in federal funding, a UR research team is about to see how effective an HIV drug is at helping people without the disease live longer and healthier ...

The Florida Department of Health is attempting to cut off access to HIV medications for thousands of Floridians.

Duygu Islek Yaras is a postdoctoral researcher at Emory University examining how inequality, stigma, and access influence ...

In a subgroup analysis of people living with HIV enrolled in PRIOH-1, pritelivir demonstrated superior lesion healing, achieving 61% complete ...

A new, daily oral tablet that combines two current HIV treatment medications, bictegravir and lenacapavir (BIC/LEN), could ...

DOR/ISL is currently at the pre-registration stage of development in the US and is expected to launch in this market in 2026, ...

Children with HIV on dolutegravir (Tivicay)-based antiretroviral therapy (ART) can safely receive the standard prophylactic ...

Antiretroviral therapies (ART) against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many of them are aging in good health.